Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 000230.KS
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Bad
0%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 0.45 0.51 0.51
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -90.08 60.34 608.52
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -20.54 2741.72 3450.39
Cash -16.33 7642.12 9133.72
Capex -2329.50 -311.93 -12.84
Free Cash Flow 38.29 -972.49 703.21
Revenue 2.06 14333.53 14043.76
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 4.52 0.33 0.32
Operating Margin 57.24 -0.02 -0.06
ROA 43.31 < 0.005 -0.01
ROE 30.46 -0.20 -0.28
ROIC -16.24 -0.01 -0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 000230.KS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 000230.KS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 000230.KS is permitted for members.